Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
Sponsor: Icahn School of Medicine at Mount Sinai
Asthma
United States
Sponsor: Scleroderma Research Foundation, Inc.
Interstitial Lung Disease Due to Systemic Disease · Scleroderma
United States
Sponsor: Sanofi
Hemophilia
United States, Belgium, Brazil, Canada, China +8 more
- Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple MyelomaActive Not Recruiting
Sponsor: University of Heidelberg Medical Center
Multiple Myeloma
Austria, Germany
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
Sponsor: Sanofi
Multiple Sclerosis
United States, Belgium, China, Italy, Japan
Sponsor: Sanofi
Neoplasm Malignant
United States, Czechia, Norway, South Korea, Spain
Sponsor: Sanofi
Atopic Dermatitis
Italy
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Bulgaria, Chile, China +11 more
- Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With AsthmaEnrolling By Invitation
Sponsor: Sanofi
Asthma
United States, Argentina, Brazil, Canada, Chile +9 more
Sponsor: Centers for Disease Control and Prevention
Pulmonary Tuberculosis
United States, Brazil, Canada, South Africa, Spain +1 more
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling By Invitation
Sponsor: Sanofi
Wheezing · Asthma
United States, Argentina, Brazil, Canada, Czechia +11 more
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Brazil, Bulgaria, Canada +9 more
- An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal PolypsActive Not Recruiting
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
United States, Australia, Canada, Chile, China +4 more
- A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareActive Not Recruiting
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Esophagitis (EoE)
United States
Sponsor: Sanofi
Rheumatoid Arthritis
United States
Sponsor: Yale University
Gaucher Disease
United States
- Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe AcneNot Yet Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Acne
Sponsor: Sanofi
RSV Immunization
Czechia
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma
United States
Sponsor: Sanofi
Alopecia Areata
United States, Argentina, Australia, Bulgaria, Canada +11 more
- A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkActive Not Recruiting
Sponsor: Sanofi
Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Polyneuropathy, Inflammatory Demyelinating, Chronic
United States, Argentina, Belgium, Brazil, Bulgaria +19 more
Sponsor: University Hospital, Clermont-Ferrand
Knee Osteoarthritis (Knee OA)
France